Process Aids Market
Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: ... Read More
Probiotics Suppliment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PROBIOTICS SUPPLIMENT INDUSTRY
2.1 Summary about Probiotics Suppliment Industry
2.2 Probiotics Suppliment Market Trends
2.2.1 Probiotics Suppliment Production & Consumption Trends
2.2.2 Probiotics Suppliment Demand Structure Trends
2.3 Probiotics Suppliment Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Lactobacillus
4.2.2 Bifidobacterium
4.2.3 Saccharomyces boulardii
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Irritable bowel syndrome
4.3.2 Inflammatory bowel disease (IBD)
4.3.3 Infectious diarrhea (caused by viruses, bacteria, or parasites)
4.3.4 Antibiotic-related diarrhea
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Lactobacillus
5.2.2 Bifidobacterium
5.2.3 Saccharomyces boulardii
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Irritable bowel syndrome
5.3.2 Inflammatory bowel disease (IBD)
5.3.3 Infectious diarrhea (caused by viruses, bacteria, or parasites)
5.3.4 Antibiotic-related diarrhea
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Lactobacillus
6.2.2 Bifidobacterium
6.2.3 Saccharomyces boulardii
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Irritable bowel syndrome
6.3.2 Inflammatory bowel disease (IBD)
6.3.3 Infectious diarrhea (caused by viruses, bacteria, or parasites)
6.3.4 Antibiotic-related diarrhea
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Lactobacillus
7.2.2 Bifidobacterium
7.2.3 Saccharomyces boulardii
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Irritable bowel syndrome
7.3.2 Inflammatory bowel disease (IBD)
7.3.3 Infectious diarrhea (caused by viruses, bacteria, or parasites)
7.3.4 Antibiotic-related diarrhea
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Lactobacillus
8.2.2 Bifidobacterium
8.2.3 Saccharomyces boulardii
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Irritable bowel syndrome
8.3.2 Inflammatory bowel disease (IBD)
8.3.3 Infectious diarrhea (caused by viruses, bacteria, or parasites)
8.3.4 Antibiotic-related diarrhea
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Lactobacillus
9.2.2 Bifidobacterium
9.2.3 Saccharomyces boulardii
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Irritable bowel syndrome
9.3.2 Inflammatory bowel disease (IBD)
9.3.3 Infectious diarrhea (caused by viruses, bacteria, or parasites)
9.3.4 Antibiotic-related diarrhea
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Activhealth (Singapore) Pte Ltd(SG)
10.1.2 NutriFlair(US)
10.1.3 Pure Healthland(US)
10.1.4 Nature's Bounty(CN)
10.1.5 Healthy Choice Naturals(US)
10.1.6 Number One Nutrition(US)
10.1.7 Sorvita Nutra Products, LLC.(US)
10.1.8 HERENEWCO LLC.(US)
10.1.9 Aspire Vitality(US)
10.1.10 Nature’s Potent(US)
10.1.11 SEROVERA(US)
10.1.12 NOW Foods(US)
10.2 Probiotics Suppliment Sales Date of Major Players (2017-2020e)
10.2.1 Activhealth (Singapore) Pte Ltd(SG)
10.2.2 NutriFlair(US)
10.2.3 Pure Healthland(US)
10.2.4 Nature's Bounty(CN)
10.2.5 Healthy Choice Naturals(US)
10.2.6 Number One Nutrition(US)
10.2.7 Sorvita Nutra Products, LLC.(US)
10.2.8 HERENEWCO LLC.(US)
10.2.9 Aspire Vitality(US)
10.2.10 Nature’s Potent(US)
10.2.11 SEROVERA(US)
10.2.12 NOW Foods(US)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table 1.Table Probiotics Suppliment Product Type Overview 2.Table Probiotics Suppliment Product Type Market Share List 3.Table Probiotics Suppliment Product Type of Major Players 4.Table Brief Introduction of Activhealth (Singapore) Pte Ltd(SG) 5.Table Brief Introduction of NutriFlair(US) 6.Table Brief Introduction of Pure Healthland(US) 7.Table Brief Introduction of Nature's Bounty(CN) 8.Table Brief Introduction of Healthy Choice Naturals(US) 9.Table Brief Introduction of Number One Nutrition(US) 10.Table Brief Introduction of Sorvita Nutra Products, LLC.(US) 11.Table Brief Introduction of HERENEWCO LLC.(US) 12.Table Brief Introduction of Aspire Vitality(US) 13.Table Brief Introduction of Nature’s Potent(US) 14.Table Brief Introduction of SEROVERA(US) 15.Table Brief Introduction of NOW Foods(US) 16.Table Products & Services of Activhealth (Singapore) Pte Ltd(SG) 17.Table Products & Services of NutriFlair(US) 18.Table Products & Services of Pure Healthland(US) 19.Table Products & Services of Nature's Bounty(CN) 20.Table Products & Services of Healthy Choice Naturals(US) 21.Table Products & Services of Number One Nutrition(US) 22.Table Products & Services of Sorvita Nutra Products, LLC.(US) 23.Table Products & Services of HERENEWCO LLC.(US) 24.Table Products & Services of Aspire Vitality(US) 25.Table Products & Services of Nature’s Potent(US) 26.Table Products & Services of SEROVERA(US) 27.Table Products & Services of NOW Foods(US) 28.Table Market Distribution of Major Players 29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 31.Table Global Probiotics Suppliment Market Forecast (Million USD) by Region 2021f-2026f 32.Table Global Probiotics Suppliment Market Forecast (Million USD) Share by Region 2021f-2026f 33.Table Global Probiotics Suppliment Market Forecast (Million USD) by Demand 2021f-2026f 34.Table Global Probiotics Suppliment Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure 1.Figure Global Probiotics Suppliment Market Size under the Impact of COVID-19, 2017-2021f (USD Million) 2.Figure Global Probiotics Suppliment Market by Region under the Impact of COVID-19, 2017-2021f (USD Million) 3.Figure Global Probiotics Suppliment Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million) 4.Figure Global Probiotics Suppliment Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million) 5.Figure Global Probiotics Suppliment Production by Region under the Impact of COVID-19, 2021-2026 (USD Million) 6.Figure Global Probiotics Suppliment Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million) 7.Figure Global Probiotics Suppliment Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million) 8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 13.Figure Lactobacillus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 14.Figure Bifidobacterium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 15.Figure Saccharomyces boulardii Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 16.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 17.Figure Irritable bowel syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 18.Figure Inflammatory bowel disease (IBD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 19.Figure Infectious diarrhea (caused by viruses, bacteria, or parasites) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 20.Figure Antibiotic-related diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 21.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 22.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 23.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 24.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 25.Figure Lactobacillus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 26.Figure Bifidobacterium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 27.Figure Saccharomyces boulardii Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 28.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 29.Figure Irritable bowel syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 30.Figure Inflammatory bowel disease (IBD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 31.Figure Infectious diarrhea (caused by viruses, bacteria, or parasites) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 32.Figure Antibiotic-related diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 34.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 35.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 36.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 37.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 38.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 39.Figure Lactobacillus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 40.Figure Bifidobacterium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 41.Figure Saccharomyces boulardii Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 42.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 43.Figure Irritable bowel syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 44.Figure Inflammatory bowel disease (IBD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 45.Figure Infectious diarrhea (caused by viruses, bacteria, or parasites) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 46.Figure Antibiotic-related diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 48.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 49.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 50.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 51.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 52.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 53.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 54.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 55.Figure Lactobacillus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 56.Figure Bifidobacterium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 57.Figure Saccharomyces boulardii Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 58.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 59.Figure Irritable bowel syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 60.Figure Inflammatory bowel disease (IBD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 61.Figure Infectious diarrhea (caused by viruses, bacteria, or parasites) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 62.Figure Antibiotic-related diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 63.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 64.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 65.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 66.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 67.Figure Lactobacillus Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 68.Figure Bifidobacterium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 69.Figure Saccharomyces boulardii Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 71.Figure Irritable bowel sy